Prescription Drug User Fee Act
Legislation in the United States / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Prescription Drug User Fee Act?
Summarize this article for a 10 year old
The Prescription Drug User Fee Act (PDUFA) was a law passed by the United States Congress in 1992 which allowed the Food and Drug Administration (FDA) to collect fees from drug manufacturers to fund the new drug approval process. The Act provided that the FDA was entitled to collect a substantial application fee from drug manufacturers at the time a New Drug Application (NDA) or Biologics License Application (BLA) was submitted, with those funds designated for use only in Center for Drug Evaluation and Research (CDER) or Center for Biologics Evaluation and Research (CBER) drug approval activities. In order to continue collecting such fees, the FDA is required to meet certain performance benchmarks, primarily related to the speed of certain activities within the NDA review process.
Long title | An Act to amend the Federal Food, Drug, and Cosmetic Act to authorize human drug application, prescription drug establishment, and prescription drug product fees and for other purposes. |
---|---|
Acronyms (colloquial) | PDUFA, DSA |
Nicknames | Dietary Supplement Act of 1992 |
Enacted by | the 102nd United States Congress |
Effective | October 29, 1992 |
Citations | |
Public law | 102-571 |
Statutes at Large | 106 Stat. 4491 |
Codification | |
Acts amended | Federal Food, Drug and Cosmetic Act |
Titles amended | 21 U.S.C.: Food and Drugs |
U.S.C. sections amended | 21 U.S.C. ch. 9, subch. VII § 379g et seq. |
Legislative history | |
|